德适-B(02526)今日盘中股价大幅上涨5.41%，引起了市场关注。
消息面上，公司此前披露的一季度业绩表现亮眼，净利润达到5.8亿元，同比增长12.3%，毛利率为38.7%，环比提升了2.1个百分点，盈利能力显著超出市场预期。同时，公司旗下的AI AutoVision已被国家药监局认定为三类创新医疗器械，监管机构对其注册批准无异议，目前仅剩程序及行政事宜待完成。若最终获批，该产品将成为国内首款智能染色体核型辅助诊断软件。基本面的改善叠加重要产品的获批预期，共同推动了股价的上涨。
德适-B(02526)今日盘中股价大幅上涨5.41%，引起了市场关注。
消息面上，公司此前披露的一季度业绩表现亮眼，净利润达到5.8亿元，同比增长12.3%，毛利率为38.7%，环比提升了2.1个百分点，盈利能力显著超出市场预期。同时，公司旗下的AI AutoVision已被国家药监局认定为三类创新医疗器械，监管机构对其注册批准无异议，目前仅剩程序及行政事宜待完成。若最终获批，该产品将成为国内首款智能染色体核型辅助诊断软件。基本面的改善叠加重要产品的获批预期，共同推动了股价的上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.